Recommended Immunization Schedules for Persons Aged 0 Through 18 Years -- United States, 2009

January 2009
MMWR: Morbidity & Mortality Weekly Report;1/2/2009, Vol. 57 Issue 51/52, pQ-1
This article presents the recommended immunization schedules for persons aged 0 through 18 years for 2009 as published by the Advisory Committee on Immunization Practices in the U.S. It notes some of the changes to the previous schedule, such as recommendations for rotavirus vaccines, routine and annual influenze vaccination and interval between tetanus and diphtheria toxoids.


Related Articles

  • Choose a healthy lifestyle.  // Southern African Journal of Epidemiology & Infection;2009, Vol. 24 Issue 3, p1 

    The article offers information on the three vaccines introduced by the Department of Health in South Africa in 2009: Pneumococcal Conjugate Vaccine-7 valent (PCV7), Rotavirus vaccine, and Pentavalent Vaccine (DTaP-IPV/Hib). It discusses pneumococcal diseases, the pathogenicity of the...

  • IMMUNIZATION.  // MPR - Physician Assistants' Edition;Spring2015, Vol. 22 Issue 1, p101 

    The article reviews several drugs for immunization including Boostrix from GlaxoSmithKline, Adacel from Sanofi Pasteur and Flucelvax from Novartis.

  • Untitled.  // American Family Physician;1/1/2008, Vol. 77 Issue 1, p117 

    The article presents the recommended immunization schedule for persons aged 0 to 18 in the U.S. Some of the suggested vaccines for infants to six-year-old children are hepatitis B vaccine, rotavirus vaccine, diphtheria and tetanus toxoids and acellular pertussis vaccine and varicella vaccine....

  • New vaccine for infants. M. M. // Prevention;Jul2006, Vol. 58 Issue 7, p144 

    The article focuses on a new vaccine, called RotaTeq, that protects against rotavirus, a stomach flu that causes diarrhea and dehydration, infecting most children by the age of five. The article recommends that the vaccine be given to infants between 6 and 32 weeks of age. The vaccine has been...

  • High Cost Is the Primary Barrier Reported by Physicians Who Prescribe Vaccines Not Included in India’s Universal Immunization Program. Kahn, Geoffrey D.; Thacker, Deep; Nimbalkar, Somashekhar; Santosham, Mathuram // Journal of Tropical Pediatrics;Aug2014, Vol. 60 Issue 4, p287 

    Haemophilus influenzae type B (Hib) vaccine, pneumococcal conjugate vaccine (PCV) and rotavirus (RV) vaccine are available in the private market in India, but, except for Hib in eight states, are not included in India’s Universal Immunization Program (UIP). Pediatricians were surveyed...

  • Immunization for the Internist. Rimland, David; McGowan Jr., John E.; Shulman, Jonas A. // Annals of Internal Medicine;Nov76, Vol. 85 Issue 5, p622 

    Outlines the practices for active and passive immunization recommended for adults. Immunization before disease exposure to tetanus and diphtheria; Types of vaccine for influenza immunization; Importance of rubella immunization for women of child-bearing age.

  • Vaccination Recommendations for Germany. Wiese-Posselt, Miriam; Tertilt, Christine; Zepp, Fred // Deutsches Aerzteblatt International;11/11/2011, Vol. 108 Issue 45, p771 

    Background: Vaccination is an effective means of preventing infectious diseases. In Germany, the Standing Vaccination Committee at the Robert Koch Institute (Ständige Impfkommission, STIKO) issues recommendations on vaccination to prevent the occurrence and spread of infectious diseases in...

  • New vaccines and update introduced in the UK this summer.  // Nursing Children & Young People;Jun2013, Vol. 25 Issue 5, p4 

    The article reports that two new vaccines to protect against influenza and diarrhoea have been added as part of the vaccination programmes for children in Great Britain from the summer of 2013.

  • Reactogenicity and Safety of DTPa Vaccine and Haemophilus influenzae Type b Conjugate Vaccine (Hib) in a Single Injection vs DTPw and Hib as Separate Injections as a Booster Vaccination in 18-Month-Old Children. Arístegui, J.; García-Corbeira, Pilar; de la Flor, J.; Dal-Ré, R.; Marés, J.; Moraga, F.; Campins, M. // Clinical Drug Investigation;2001, Vol. 21 Issue 1, p9 

    Objective: To compare the reactogenicity and safety of the administration of diphtheria-tetanus-acellular pertussis (DTPa) and Haemophilus influenzae type b conjugate (Hib) vaccines in one injection with those of the simultaneous administration of diphtheria-tetanus-whole cell pertussis (DTPw)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics